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1. Introduction 
Both heat inactivation experiments and mixed sub- 
strate incubations have demonstrated that the human 
intestinal sucrase and isomaltase activities are exerted 
by different enzymes [1-3] .  Separation techniques, 
such as gel filtration [4], ion-exchange chromatog- 
raphy [5], and gradient ultracentrifugation [6] have 
generally failed to separate the two enzymes, but 
shown that they occur bound together in a complex 
in solubilized mucosal homogenates. Recently, how- 
ever, Yamashiro and Gray [7] mentioned in an ab- 
stract hat the complex could be split by dialysis 
against 6 M urea with 0.01 M mercaptoethanol. Free 
isomaltase and sucrase could then be separated by gra- 
dient ultracentrifugation. To date, however, no fur- 
ther experimental details have been published. 
In Sephadex G-200 chromatograms an additional 
sucrase peak (sucrase-1) without concomitant isomal- 
tase activity has been reported [4]. Sucrase-1 was orig- 
inally interpreted as a separate nzyme different from 
sucrase in the sucrase-isomaltase complex (sucrase-2) 
[4, 8], but is now believed to arise from the complex 
by inactivation or removal of the isomaltase moiety 
15,9,10]. 
The rabbit small-intestinal sucrase-isomaltase com- 
plex has been isolated and characterized xtensively in
another laboratory [9-12].  The purification proce- 
dure is based primarily on the enzyme-substrate-like 
interaction with Sephadex, which results in an adsorp- 
tion and retardation of the solubilized complex on 
Sephadex G-200 columns. The same purification pro- 
cedure has also been utilized for an immunochemical 
study of the human intestinal sucrase-isomaltase com- 
plex [ 13]. Recently the separation of free rabbit iso- 
maltase after inactivation and separation of the sucrase 
moiety by incubation at pH 9.2 was reported [12, 14]. 
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The present communication reports the appearance 
of free sucrase and isomaltase, both in active form, in 
addition to the sucrase-isomaltase complex, after 
papain solubilization of human small-intestinal muco- 
sal homogenates according to the procedure usually 
used [ 15]. Separation of the different components i  
carried out with gel filtration on Bio-Gel P-300, fol- 
lowed by affinity chromatography on Sephadex G- 
200. 
2. Methods and results 
A mucosal homogenate from the proximal jejunum, 
obtained surgically and prepared as described previ- 
ously [ 16], was ultracentrifuged 100 000 g for 60 
min. The supernatant contained about 10% of the di- 
saccharidase activities. Chromatography of the super- 
natant on Bio-Gel P-300 at room temperature gave 
one small peak of sucrase and isomaltase activity at 
the void volume and a major peak with Kay = 0.08 
(not illustrated). The sediment was then treated with 
papain in potassium phosphate buffer [15], which 
made about 90% of the originally particle-bound mal- 
tase, isomaltase and sucrase activities oluble after 
another ultracentrifugation. 
Chromatography of the papain solubilized material 
on a Bio-Gel P-300 column is shown in fig. 1 a. A ma- 
jor peak containing about 80% of the sucrase and iso- 
maltase activities was eluted with Kay = 0.08. This 
was obviously the sucrase-isomaltase complex. The 
remaining 20% of the different et-glucosidase activities 
were eluted in a second peak with Kay = 0.18, indicat- 
ing a considerably ower molecular weight. Thus we 
suspected that the second peak contained free sucrase 
and free isomaltase and tried to separate the two ac- 
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Fig. 1. a) Separation of papain-solubi]ized material from hu- 
man jejunal mucosa on a Bio-Gel P-300 column (length 95 
cm, diameter 1.5 cm; buffer 0.01 M Na-malate pH 6 with 
0.077 M NaC1 and 0.077 M KC1). Two peaks with sucrase, 
isomaltase and maltase activity were separated; b) Re-chro- 
matography of one fraction (86.6-87.8 ml) of the second 
peak in fig. la on a Sephadex G-200 c~lumn (length 95 cm, 
diameter 1cm;buffer as in fig. la). The sucrase was com- 
pletely separated from the isomaltase and both peaks had 
maltase activity. 
tivities on Sephadex G-200, which is known to retard 
intestinal isomaltase activity strongly [9]. The result 
is shown in fig. lb. Complete separation of the su- 
crase from the isomaltase was obtained. Both peaks 
had maltase activity. The isomaltase peak had also 
glucoamylase activity. The Kay of the sucrase was 
0.26 which is in agreement with the Kd-value of 0.23 
reported for sucrase-1 [7]. Free glucose appeared in 
the eluate between 60 and 85 ml with maximum at 
73 ml. 
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3. Discussion 
These results how that the solubilization with pa- 
pain released not only the sucrase-isomaltase com- 
plex as previously known, but also some free sucrase 
and free isomaltase from the membrane fragments of 
human small-intestinal homogenate. Thus, the en- 
zyme peak which in literature has been named sucrase- 
1 is most probably free sucrase. The free isomaltase, 
however, cannot be separated from the sucrase-iso- 
maltase complex by Sephadex G-200 chromatography, 
since both are interacting with the gel in a similar way 
and are therefore retarded. This is why chromatog- 
raphy on Bio-Gel P-300 must be included as a first 
separation step, in the way we have described above. 
The separation of sucrase from isomaltase in a 
preparative scale allows an individual characterization 
of the two enzymes, which is in progress. 
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